Role of Placenta-Derived Mesenchymal Stem Cells in Human Health and Disease
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cell Biology and Pathology".
Deadline for manuscript submissions: closed (31 July 2024) | Viewed by 2657
Special Issue Editor
Interests: pediatric urology and surgery; stem cells
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The placenta is a temporary organ that regulates the exchange of nutrients, metabolites, gases, antibodies, and all that is required to establish the environment where a fetus can develop until birth. Several cell types of maternal and fetal origins contribute to accomplishing these functions. At full term, the placenta is usually discarded but it represents an abundant source of mesenchymal stromal cells (MSCs) and thus could provide cell precursors for cell therapy. In addition to their self-renewal ability, immunomodulatory properties, and plasticity, placenta-derived MSCs are neither teratogenic nor liable of ethical limitations.
As compared to MSCs derived from bone marrow and from other tissues, placenta-derived MSCs remain under-investigated. Given the development of tissue engineering, cellular therapies and artificial organs, there will be an increasing need for cells endowed with plasticity and trophic properties. This Special Issue aims to collect reviews and research papers describing the functional properties and the potential of MSCs and any other aspect that may help to take advantage of this precious resource for regenerative therapies.
Dr. Luca Giacomello
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
